HAVCR2 and rheumatoid arthritis: Gal–9 seems to be reciprocally upregulated to regulate the rheumatoid inflammation; however, sTIM–3, which is elevated in RA patients, can competitive inhibit this co–inhibitory Gal–9/TIM–3 pathway.